Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 6/20 | 0.33 |
| ▸ | CA2 | P00918 | 6/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL485743 | 1.00 | CYP3A4 (0.38) | CYP3A4TDP1ESR1ESR2CA1 | |
| SCHEMBL735405 | 1.00 | CYP3A4 (0.38) | CYP3A4TDP1ESR1ESR2CA1 | |
| SCHEMBL7625046 | 0.98 | CYP3A4 (0.36) | CYP3A4TDP1ESR1ESR2CA1 | |
| SCHEMBL7618395 | 0.98 | CYP3A4 (0.36) | CYP3A4TDP1ESR1ESR2CA1 | |
| Hydrochloric Acid SCHEMBL2241908 | 0.97 | CYP3A4 (0.35) | CYP3A4TDP1ESR1ESR2CA1 | |
| Hydrochloric Acid SCHEMBL6760978 | 0.97 | CYP3A4 (0.35) | CYP3A4TDP1ESR1ESR2CA1 | |
| Hydrochloric Acid SCHEMBL6764244 | 0.97 | CYP3A4 (0.35) | CYP3A4TDP1ESR1ESR2CA1 | |
| SCHEMBL6763721 | 0.94 | CA2 (0.35) | CA1CA2 | |
| SCHEMBL7618005 | 0.92 | CA1 (0.35) | CA1CA2 | |
| Hydrochloric Acid SCHEMBL3003099 | 0.90 | CA1 (0.34) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6727390-B2 | INCREASING FLUOROUS NATURE OF A COMPOUND BY REACTING THE COMPOUND WITH OR TAGGING THE COMPOUND WITH FLUOROUS PHOSPHINES AND PHOSPHINE OXIDES | UNIVERSITY OF PITTSBURGH | 2004-04-27 | — | — | US | disclosed |
| US-20020183521-A1 | Fluorous phosphines and phosphine oxides | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-12-05 | — | — | US | disclosed |
| WO-2002081486-A1 | FLUOROUS PHOSPHINES AND PHOSPHINE OXIDES | UNIVERSITY OF PITTSBURGH (US) | 2002-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020183521-A1 | Fluorous phosphines and phosphine oxides | PFAS, AFF1, AFF2 | CYP3A4 1619/4885TDP1 3424/4885ESR1 1295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.